Pfizer is reportedly leading a new wave of 2026 US drug price hikes, planning increases on about 80 medicines, Reuters said. Most rises are below 10%, though Comirnaty will climb 15%. Industry-wide pricing updates typically peak in January, even as the White House pushes drugmakers to rein in costs.